{"title":"Treatment Outcomes of the Inferior Meatus Augmentation Procedure with Autologous Costal Cartilage for Empty Nose Syndrome.","authors":"Jang Wook Gwak, Yong Ju Jang","doi":"10.21053/ceo.2025-00107","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Empty nose syndrome (ENS) is a rare postoperative complication arising from turbinate surgery. Here, we report our clinical experience and comprehensive analysis of the inferior meatus augmentation procedure with autologous costal cartilage (IMAP-ACC) for ENS.</p><p><strong>Methods: </strong>We conducted a retrospective review of medical records of patients diagnosed with ENS and underwent IMAP-ACC at a tertiary referral center between November 2015 and November 2023. Symptom improvement was assessed by the Empty Nose Syndrome 6-Item Questionnaire (ENS6Q) score before and after the IMAP. Additionally, perioperative complications and revision surgery cases were investigated.</p><p><strong>Results: </strong>Out of the 32 patients that underwent IMAP-ACC, the clinical analysis included 20 patients (16 males, 4 females) with a mean age of 39.1 ± 11.5 years and mean follow-up of 61.2 ± 28.8 months. The mean ENS6Q score improved significantly from 17.5 ± 5.3 preoperatively to 9.1 ± 6.0 at the last follow-up (p<0.001). In the subgroup analysis of 16 patients whose early follow-up data were available, significant improvements were observed in the ENS6Q scores at both the early (7.8 ± 5.7) and long-term follow-up (8.6 ± 6.5) compared to the preoperative value (18.2 ± 5.6). Among 32 patients, nasal obstruction was the most common perioperative complication (34.4%), necessitating reoperation in four patients (12.5%). Most complications were managed well with a conservative approach.</p><p><strong>Conclusion: </strong>IMAP-ACC demonstrated its role as a valuable treatment option for patients with ENS, showing sustained effectiveness over a long-term follow-up period.</p>","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2025-00107","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Empty nose syndrome (ENS) is a rare postoperative complication arising from turbinate surgery. Here, we report our clinical experience and comprehensive analysis of the inferior meatus augmentation procedure with autologous costal cartilage (IMAP-ACC) for ENS.
Methods: We conducted a retrospective review of medical records of patients diagnosed with ENS and underwent IMAP-ACC at a tertiary referral center between November 2015 and November 2023. Symptom improvement was assessed by the Empty Nose Syndrome 6-Item Questionnaire (ENS6Q) score before and after the IMAP. Additionally, perioperative complications and revision surgery cases were investigated.
Results: Out of the 32 patients that underwent IMAP-ACC, the clinical analysis included 20 patients (16 males, 4 females) with a mean age of 39.1 ± 11.5 years and mean follow-up of 61.2 ± 28.8 months. The mean ENS6Q score improved significantly from 17.5 ± 5.3 preoperatively to 9.1 ± 6.0 at the last follow-up (p<0.001). In the subgroup analysis of 16 patients whose early follow-up data were available, significant improvements were observed in the ENS6Q scores at both the early (7.8 ± 5.7) and long-term follow-up (8.6 ± 6.5) compared to the preoperative value (18.2 ± 5.6). Among 32 patients, nasal obstruction was the most common perioperative complication (34.4%), necessitating reoperation in four patients (12.5%). Most complications were managed well with a conservative approach.
Conclusion: IMAP-ACC demonstrated its role as a valuable treatment option for patients with ENS, showing sustained effectiveness over a long-term follow-up period.
期刊介绍:
Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.
CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.
The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.